Human Resources
Top 5 talent acquisition & recruitment trends shaping 2021 – Interview

Human Resources: The Australian Pharma, MedTech and Biotech sectors have spent much of the past ten months adapting to extraordinary circumstances and navigating a new way of working internally and externally in servicing their customers.
In an interview with Health Industry Hub, subject matter expert, Vanessa Meikle from Hunton Executive explores the key trends in talent acquisition and recruitment shaping 2021.
Key trends explored:
- The impact of the COVID-19 pandemic on the Australian Pharma, MedTech and Biotech workforce.
- The organisational roles impacted the least and those that grew in demand during this time.
- Talent gaps in the post-COVID era to drive organisational growth.
- Top 5 workforce trends to watch in 2021.
- Key tips for leaders navigating the new normal, and for individuals currently looking for employment in the Pharma, MedTech and Biotech sectors.
About Vanessa Meikle
Vanessa Meikle is the CEO and Founder of Hunton Executive. She is an executive search management consultant and executive career coach with over 18 years’ experience specifically within the life sciences and healthcare industries. She helps employers accelerate their business performance through the attraction, recruitment, and retention of their leaders and she helps executives accelerate their careers by guiding them through their career transition and accessing career defining job opportunities.
News & Trends - MedTech & Diagnostics

Sussan Ley breaks ground as first female opposition leader amid Liberal party shake-up
Sussan Ley has made history as the country’s first female opposition leader, edging out former shadow treasurer Angus Taylor in […]
MoreNews & Trends - MedTech & Diagnostics

New procedure shows durable impact in type 2 diabetes
Medtech company, Endogenex, has unveiled promising data from an Australian clinical trial that could mark a turning point in type […]
MoreNews & Trends - Pharmaceuticals

AI rewrites the script on androgen deprivation therapy in prostate cancer
Artificial intelligence is showing promise in reshaping treatment decisions for men undergoing radiation therapy and androgen deprivation therapy (ADT) for […]
MoreNews & Trends - MedTech & Diagnostics

MSAC to assess CGM funding for expanded access in diabetes management
Applications from Abbott Australasia and Australasian Medical & Scientific Limited (AMSL) for public funding of continuous glucose monitoring (CGM) devices […]
More